AbbVie (ABBV)

When investors take a risk-off attitude, stocks with attractive, growing dividends are often their safe-haven option.

The healthcare sector outperformed the rest of the market over the past week.

This big pharma stock checks off a lot of boxes.

Looking past stocks because they trade at high trailing earnings multiples can be a costly mistake for investors.

One is a well-known pharmaceutical company; the other is the king of the medical device segment.

Over the past six months, AbbVie’s shares (currently trading at $211.15) have posted a disappointing 9.8% loss, well below the S&P 500’s 11.5% gain. This mig...

All High Quality Names

How does a rising 3.4% dividend and a growing portfolio of drugs sound?

It's not the news that AbbVie needed, given the challenging year it is having.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

This mortgage REIT generates income by originating and managing commercial real estate loans across the United States.

Blackstone Mortgage Trust originates senior commercial real estate loans globally, generating income primarily from interest and dividends.

AbbVie (NYSE:ABBV) told shareholders at its annual meeting that 2025 was “another excellent year” for the company, citing record sales, stronger-than-expected revenue and continued investment in its drug pipeline and business development. Rob Michael, AbbVie’s chairman and chief executive officer,

They have combined for 118 years of consecutive dividend increases.

These stocks check off multiple boxes for income investors.

AbbVie’s first quarter results for 2026 exceeded management’s guidance midpoint and internal expectations, with adjusted earnings per share and revenue comin...

By holding these top income stocks in your portfolio, you can have a position in some great companies while also generating cash flow each month.

But is the stock a buy on the dip?

These stocks offer high yields, attractive valuations, significant upside, and can be terrific investments to buy right now.

The timing is great for scooping up shares of these well-run companies.

Pharmaceutical company AbbVie (NYSE:ABBV) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 4.8% year on year to $13.98 billion. Its non-G...

Sonoco Products Company delivers packaging solutions to global consumer and industrial markets, with a reported dividend yield of 4.2%.

What Happened? Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 3.5% in the afternoon session after the company reported first-quarter results that...